20 Mar 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Sunshine Heart, a medical devices company listed on Nasdaq and ASX, has appointed that Mr Jon W Salveson to the company's board of directors. Mr Salveson is the vice chairman, investment banking, and chairman of the Healthcare Investment Banking Group at Piper Jaffray. He also serves on the board of CryoLife, a leading medical device company focused on cardiac and vascular surgery.
Sunshine Heart is an early-stage global medical device company committed to the commercialization of the C-Pulse System, an implantable, non-blood contacting, heart assist therapy for the treatment of moderate to severe heart failure.
"Jon brings extensive corporate transaction and financing experience to the company that will play an integral role as we mature in the clinic and on corporate development fronts," said Mr John Erb, chairman of Sunshine Heart's board of directors. "With C-Pulse's pivotal trial and European post-market study about to commence, we welcome his strategic input as the company transitions to the next phase of growth."
Mr Salveson joined Piper Jaffray in 1993 as an associate, was elected managing director in 1999, and was named the group head of Piper Jaffray's International Healthcare Investment Banking Group in 2001. Mr Salveson was appointed global head of investment banking and a member of the executive committee of Piper Jaffray in 2004, and has served in his present position as vice chairman, Investment Banking since July 2010.